elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39164346-FA91BE82-6EC4-47EC-AF71-5E88BBEAAB9A
Q39164346-FA91BE82-6EC4-47EC-AF71-5E88BBEAAB9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39164346-FA91BE82-6EC4-47EC-AF71-5E88BBEAAB9A
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
P2860
Q39164346-FA91BE82-6EC4-47EC-AF71-5E88BBEAAB9A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39164346-FA91BE82-6EC4-47EC-AF71-5E88BBEAAB9A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69a658edb60d4528b6b85d86d81ae1380be09de4
P2860
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease.